dpp-4 inhibitors and glp-1 agonists receptor or inhibitors: How to guide the clinician? The Role of DPP-4 Inhibitors
Description
Tirzepatide is optimized for GIP and GLP-1 receptor engagement with minimal glucagon-receptor activity, while retatrutide retains GLP-1 and GIP affinity but introduces substitutions that restore meaningful glucagon-receptor binding

Rights and permissions About this article Cite this article Andersen, A., Lund, A., Knop, F.K
Protein, protein, protein

If weekly dosing, consider holding a week before the procedure

GLP-1 receptor agonists have rapidly emerged as one of the most important therapeutic breakthroughs in metabolic medicine

10.2147/IBPC.S150628 26
